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Facial lipoatrophy is one of the most diﬃcult complication in the patients with lupus profundus. In this paper, we present a case of
a 55-year-old woman aﬀected by lupus profundus, with a grade V lipoatrophy, treated with lipofilling technique. No complications
were observed and results at 12 months were stable, natural, and symmetric.
1. Introduction
Lupus profundus [1–6] is a clinical condition characterized
by subcutaneous nodular lesions localized at the face, arms,
legs, trunk, and abdominal region (see Figure 1). Lipoat-
rophy follows the nodular stage after its resolution. Lupus
profundus incidence is between 1% and 3% in patient
with LES. Autoimmunitary etiology is confirmed by low
complement levels and presence of antinucleus antibody.
Manifold complications are possible in lupus profundus:
lipoatrophy, alopecia [7], enophthalmos [8, 9], central retinal
artery occlusion [10], mastitis [11], thrombophlebitis [12],
and proptosis [13]. Despite its benignity, lipoatrophy is
psychologically important in everyday life. Facial lipoatrophy
can be considered following a grading scale [14] from first
to fifth grade. Diﬀerent strategies were proposed in order to
solve this situation: nonabsorbable fillers such as polymethy-
lacrylate [15] do not give striking results, and complications
[16], as granulomatous “rubberizing” reaction, are rare but
possible. Free flaps, especially anterolateral thigh flap [17]
and temporal flap [18], are rarely used giving the diﬃculty of
the surgical procedure and the unnatural results. Yoshimura’s
CAL technique [19] is a valid and quite stable option but
requires adipose-derived stem cells extraction in laboratory,
7–10 days for cell culture, and a double step surgical
procedure (fat extraction and fat injection). Authors report
their experience regarding a case of patient with Lupus
Profundus treated with lipofilling technique [20–22].
2. Matherials and Methods
A 55-year-old patient suﬀering from lupus panniculitis,
treated with hydroxychloroquine, methotrexate, and metil-
prednisone, showed clinical signs of lipoatrophy in facial,
abdominal, and mammary areas. Patient was submitted to
three surgical procedures of lipofilling with Coleman’s
technique [23] at 6-month distance among every step. First
adipose graft was 12 cc, second 15 cc, and third 18 cc, picked
from abdominal fat. Submalar, parotideal, perioral, and
mandibular sites was grafted with adipose tissue, using 9
French microcannules. Only one hole for each side of the
face was necessary to introduce the graft. Every procedure
was performed in outpatient surgery and in local anesthesia
with sedation.
3. Results
No complications due to infections or surgical technique
were observed after each procedure. A mild intolerance to
the antibiotic therapy was easily solved. 12-month evalu-
ation after third reconstructive step showed the stability
2 Case Reports in Dermatological Medicine
Figure 1: Initial condition of the patient.
Figure 2: Final result after three lipofilling procedures at 12-month
followup.
of the result and the emptiness localized in the submalar
and parotideal region was totally filled (see Figure 2). Also
the aspect of typical cutaneous lesions of lupus syndrome
was improved. The first of three grafts did not supply an
acceptable result as because of copious smoking by the
patient during immediate postoperatively period. Final result
was natural and symmetric.
4. Discussion
Facial lipoatrophy is an important issue for the aesthetic
acceptance of a patient aﬀected by lupus profundus. In our
case a triple lipofilling procedure has given stable results at
12-month followup. Longer followup would be necessary to
prove the persistence of the results.
Despite its rarity, severe complications of lipofilling in
the treatment of facial lipoatrophy are reported [24]. The
impairment of facial nerve may represent one of the prob-
lems due to surgical technique.
Fat grafting should be examined as option in manage-
ment of three-dimensional defects of facial lipoatrophy: the
minimal invasivity, the simplicity of the surgical procedure,
the fast convalescence, and the possibility of modulating the
quantity of the graft are the main benefits of this option.
In our experience one of the most essential factors in
the persistence of the graft was patient’s smoking habit.
We believe that absolute abstinence in smoking in the
months after the surgery would have dramatically improved
the final results and decreased the number of procedures
needed. Moreover, we repute that, as demonstrated in
breast augmentation [25], new automated devices extracting
adipose stem cells would improve the graft persistence.
5. Conclusions
Lupic panniculitis is a relatively rare condition that causes
facial lipoatrophy. Diﬀerent strategies were adopted in order
to fill the soft tissue defect. Nonabsorbable filler and free
flaps are two of the options available. Themanagement of the
above-mentioned case provided good results. No complica-
tions were observed and the period of healing was minimal.
Photographic evaluation demonstrates the persistence of
adipose tissue and patient satisfaction degree was excellent.
Hence, we believe that lipofilling would represent a simple,
cheap, and fast method to face an important complication of
lupus profundus, as facial lipoatrophy.
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